Duration of Hospitalization (days)
| . | Filgrastim . | Placebo . | |
|---|---|---|---|
| Induction therapy | |||
| Median | 23.0 | 29.0 | P = .00018-150 |
| Quartiles | 18.0-34.0 | 22.0-40.0 | |
| Range | 2-104 | 7-93 | |
| Number of patients | 259 | 262 | |
| Induction and consolidation | |||
| Median | 42.0 | 55.0 | P = .00018-150 |
| Quartiles | 36.0-51.0 | 45.0-65.0 | |
| Range | 15-140 | 23-114 | |
| Number of patients | 162 | 157 |
| . | Filgrastim . | Placebo . | |
|---|---|---|---|
| Induction therapy | |||
| Median | 23.0 | 29.0 | P = .00018-150 |
| Quartiles | 18.0-34.0 | 22.0-40.0 | |
| Range | 2-104 | 7-93 | |
| Number of patients | 259 | 262 | |
| Induction and consolidation | |||
| Median | 42.0 | 55.0 | P = .00018-150 |
| Quartiles | 36.0-51.0 | 45.0-65.0 | |
| Range | 15-140 | 23-114 | |
| Number of patients | 162 | 157 |
Durations counted from day 6 of induction 1.
Wilcoxon Rank Sum Test.